Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chemokine Therapeutics Corp
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Chemokine Therapeutics Corp since year 2005.
Table 2 shows the detailed insider transactions of Chemokine Therapeutics Corp since 2005.
The reporting company's ticker symbol is CHKT. The reporting company's CIK number is 1092959.
The total value of stock buying since 2005 is $503,329.
The total value of stock sales since 2005 is $4,269.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2009-01-15||Salari Hassan (10% Owner)||Buy||256,900||.01||2,569|
|2009-01-12||Salari Hassan (10% Owner)||Buy||34,000||.01||340|
|2009-01-09||Salari Hassan (10% Owner)||Buy||314,500||.02||4,717|
|2008-08-27||Salari Hassan (10% Owner)||Buy||1,390,000||.07||100,079|
|2008-08-25||Evans Donald Rm (V.P. Corporate Communications)||Sale||44,200||.09||4,110|
|2008-08-22||Evans Donald Rm (V.P. Corporate Communications)||Buy||55,000||.08||4,125|
|2008-08-22||Evans Donald Rm (V.P. Corporate Communications)||Sale||1,450||.11||159|
|2008-06-13||Kowalchuk George M (Director)||Buy||666,666||.15||99,999|
|2008-06-13||Salari Hassan (Chief Scientific Officer)||Buy||80,000||.15||12,000|
|2008-04-16||Salari Hassan (Chief Scientific Officer)||Buy||50,000||.18||9,000|
|2008-04-10||Salari Hassan (Pres./Chief Scientific Officer)||Buy||50,000||.16||8,000|
|2008-02-07||Bahadori Reza (Director)||Buy||300,000||.20||60,000|
|2008-02-07||Byrd Bernard C Ii (Director)||Buy||300,000||.20||60,000|
|2008-02-07||Kuhn Brian (Director)||Buy||300,000||.20||60,000|
|2008-02-07||Korz Walter (Vice President, Drug Dev.)||Buy||50,000||.20||10,000|
|2008-02-07||Salari Hassan (Pres./Chief Scientific Officer)||Buy||312,500||.20||62,500|
|2008-02-07||Jaffer Bashir (Chief Financial Officer)||Buy||50,000||.20||10,000|
Insider trading activities including stock purchases, stock sales, and option exercises of CHKT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Chemokine Therapeutics Corp (symbol CHKT, CIK number 1092959) see the Securities and Exchange Commission (SEC) website.